Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed) |
PA-20-227 |
04/16/2023 |
|
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research |
PA-18-876 (R01 Clinical Trial Not Allowed) |
09/08/2021 |
|
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research |
PA-18-902 (R01 Clinical Trial Optional) |
09/08/2021 |
|
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression |
PA-18-739 (R21 Clinical Trial Optional) |
05/08/2021 |
|
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression |
PA-18-738 (R01 Clinical Trial Optional) |
05/08/2021 |
|
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention |
PAR-19-252 (R21 Clinical Trial Optional) |
11/09/2021 |
- Adductomics Research Program
|
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention |
PAR-19-251 (R01 Clinical Trial Optional) |
11/09/2021 |
- Adductomics Research Program
|
Biology of Bladder Cancer |
PAR-19-183 (R01 Clinical Trial Optional) |
05/08/2022 |
- Prostate and Urologic Cancer
|
Biology of Bladder Cancer |
PAR-19-184 (R21 Clinical Trial Optional) |
05/08/2022 |
- Prostate and Urologic Cancer
|
Biology of Lung, and Head and Neck Preneoplasias |
PA-17-460 (R21 - Clinical Trial Not Allowed) |
01/08/2021 |
- Lung and Upper Aerodigestive Cancer
|
Biology of Lung, and Head and Neck Preneoplasias |
PA-17-459 (R01) |
01/08/2021 |
- Lung and Upper Aerodigestive Cancer
|
Cancer Prevention and Control Clinical Trials Grant Program |
PAR-21-035 (R01 Clinical Trial Required) |
01/08/2024 |
- Breast and Gynecologic Cancer
|
Cancer Prevention and Control Clinical Trials Grant Program |
PAR-18-559 (R01 Clinical Trial Required) |
01/08/2021 |
- Breast and Gynecologic Cancer
- Gastrointestinal and Other Cancers
- Lung and Upper Aerodigestive Cancer
- Prostate and Urologic Cancer
|
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research |
PAR-19-113 (R01 Clinical Trial Optional) |
01/08/2022 |
|
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies |
PAR-19-325 (R01 Clinical Trial Optional) |
02/12/2022 |
- Community Oncology and Prevention Trials
|
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment |
PA-18-917 (R01 - Clinical Trial Optional) |
09/08/2021 |
- Supportive Care and Symptom Management
|
Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required) |
PAR-20-134 |
06/09/2021 |
|
Diet and Physical Activity Assessment Methodology |
PAR-18-857 (R21 Clinical Trial Not Allowed) |
09/08/2021 |
|
Diet and Physical Activity Assessment Methodology |
PA-18-856 (R01 Clinical Trial Not Allowed) |
09/08/2021 |
|
Exploratory/Developmental Clinical Research Grants in Obesity |
PA-18-720 (R21 Clinical Trial Optional) |
05/08/2021 |
|
Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required) |
PAR-20-133 |
06/09/2021 |
|
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer |
PAR-19-264 (R01 Clinical Trial Optional) |
12/11/2021 |
- Consortium for Imaging and Biomarkers
|
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
PA-19-112 (R01 Clinical Trial Optional) |
01/08/2022 |
- Supportive Care and Symptom Management
|
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity |
PA-19-111 (R21 Clinical Trial Optional) |
01/08/2022 |
- Supportive Care and Symptom Management
|
Mechanisms, Models, Measurement, and Management in Pain Research |
PA-18-159 (R21 Clinical Trial Optional) |
05/08/2021 |
- Supportive Care and Symptom Management
|
Mechanisms, Models, Measurement, and Management in Pain Research |
PA-18-141 (R01 Clinical Trial Optional) |
05/08/2021 |
- Supportive Care and Symptom Management
|
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain |
PA-19-201 (R21 Clinical Trial Optional) |
05/08/2022 |
- Supportive Care and Symptom Management
|
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain |
PA-19-200 (R01 Clinical Trial Optional) |
05/08/2022 |
- Supportive Care and Symptom Management
|
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer |
PAR-19-199 (R21 Clinical Trial Not Allowed) |
11/09/2021 |
|
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer |
PAR-19-198 (R01 Clinical Trial Not Allowed) |
11/09/2021 |
|
NCI Clinical and Translational Exploratory/Developmental Studies |
PAR-19-356 (R21 Clinical Trial Optional) |
07/21/2022 |
- Breast and Gynecologic Cancer
|
Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection |
NOT-CA-20-067 (R01 Clinical Trial Not Allowed) |
01/08/2023 |
|
Notice of Extension of the Expiration Date of PAR-18-654 "Basic Research in Cancer Health Disparities" |
NOT-CA-20-089 (R01 Clinical Trial Not Allowed) |
02/09/2021 |
- Gastrointestinal and Other Cancers
|
Notice of Extension of the Expiration Date of PAR-18-655 "Exploratory/Developmental Grants Program for Basic Research in Cancer Health Disparities" |
NOT-CA-20-090 (R21 Clinical Trial Not Allowed) |
02/19/2021 |
- Gastrointestinal and Other Cancers
|
Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis |
NOT-CA-20-054 |
01/26/2021 |
- All DCP Major Programs & Research Groups
|
Notice of Special Interest (NOSI): Advancing Head and Neck Cancer Early Detection Research (AHEAD) |
NOT-CA-20-031 |
01/08/2022 |
|
Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions |
NOT-CA-20-044 |
05/08/2023 |
|
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine |
PAR-18-841 (U24 - Clinical Trial Optional) |
06/15/2021 |
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival |
PAR-18-892 (R21 Clinical Trial Optional) |
09/08/2021 |
|
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival |
PAR-18-893 (R01 Clinical Trial Optional) |
09/08/2021 |
|
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
01/08/2023 |
|
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) |
PAR-20-266 |
06/20/2023 |
- Supportive Care and Symptom Management
|
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes |
PAR-20-277 (R21 Clinical Trials Not Allowed) |
09/08/2022 |
|
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes |
PAR-20-276 (R01 Clinical Trial Not Allowed) |
09/08/2022 |
|
Symptom Cluster Characterization in Chronic Conditions |
PA-17-462 (R01) |
01/08/2021 |
- Supportive Care and Symptom Management
|
Symptom Cluster Characterization in Chronic Conditions |
PA-17-461 (R21) |
01/08/2021 |
- Supportive Care and Symptom Management
|
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
08/12/2021 |
- Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
|
Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
PA-20-252 |
04/16/2022 |
|